INJECTION SITE EXTRAVASATION

This adverse event was reported 12351 times

These drugs are most commonly taken by patients reporting INJECTION SITE EXTRAVASATION:

# Drug Count
0 ADALIMUMAB 1718
1 ETANERCEPT 1528
2 METFORMIN 704
3 METFORMIN ER 500 MG 679
4 METFORMIN ER 750 MG 679
5 METHOTREXATE SODIUM 502
6 EXENATIDE 494
7 PREDNISONE 488
8 METHOTREXATE 486
9 ACETAMINOPHEN 381
See all common drugs associated with INJECTION SITE EXTRAVASATION

INJECTION SITE EXTRAVASATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Adenosine Receptor Agonist [EPC] 361 0.0489
1 PCSK9 Inhibitor [EPC] 300 0.0116
2 Provitamin D2 Compound [EPC] 232 0.0078
3 Human Immunoglobulin G [EPC] 142 0.0067
4 Interleukin-5 Antagonist [EPC] 4 0.0058
5 Recombinant Human Growth Hormone [EPC] 122 0.0055
6 Interferon alfa-2b [EPC] 9 0.0048
7 Endoglycosidase [EPC] 8 0.0043
8 Photoenhancer [EPC] 16 0.0041
9 CD38-directed Cytolytic Antibody [EPC] 24 0.0041
See all drug classes enriched for association with INJECTION SITE EXTRAVASATION